Granite Investment Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Granite Investment Partners, LLC

  • $2.21 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019
SELL
$299.6 - $414.82 $6.5 Million - $9.01 Million
-21,710 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $178,970 - $211,433
481 Added 2.27%
21,710 $8.92 Million
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $2.97 Million - $3.56 Million
8,831 Added 71.23%
21,229 $7.93 Million
Q3 2018

Nov 08, 2018
BUY
$351.14 - $408.51 $4.35 Million - $5.06 Million
12,398 New
12,398 $5.01 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email